BioSpace News Archive

PANTHERx Rare Pharmacy has again been recognized as the winner of the annual, national Specialty Pharmacy Patient Choice Award™.

Grand River Hospital Foundation is honoured to announce a gift from Equitable Life of Canada for a total of $4.6 million.

Fluidigm Corporation, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced its new Therapeutic Insights Services business, designed to provide researchers with sample-to-answer mass cytometry and Imaging Mass Cytometry™ services for a broad range of research needs.

Company initiates development of CLBS119 for the repair of COVID-19 induced lung damage and expands its proprietary CD34+ cell therapy portfolio

Conatus Pharmaceuticals Inc. convened and adjourned its special meeting of stockholders in order to obtain a quorum and specific stockholder approvals required pursuant to the terms of its merger agreement with Histogen Inc.

New ATLL data presented in the first quarter; Company plans to request a meeting with the FDA on a regulatory pathway for cobomarsen in ATLL during Q2 2020

Important progress advancing COVID-19 STARR™ mRNA vaccine candidate (LUNAR-COV19); New preclinical data demonstrate robust immunogenicitywith a single, low dose

Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and diseases associated with the microbiome, reported financial results for the first quarter ended March 31, 2020 and provided an update on recent corporate progress.

OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, reported its stand-alone financial and operating results for the three months ended March 31, 2020 and provided a business update.

Codexis, Inc., a leading protein engineering company, announces financial results for the three months ended March 31, 2020 and provides a business update.